Jeju-Japan fund backs cross-border healthcare startup Mednext
What's the deal? MednextDealroom has a profile for this one. Try Dealroom →, a cross-border healthcare platform connecting Korean and Japanese medical demand, has raised a seed round from the Jeju Japan Cross-Border Personal Investment Association No. 1. The Jeju Center for Creative Economy & Innovation announced the deal on November 9; the amount was not disclosed.
What does it do? Founded in June 2026, Mednext links hospitals, pharmacies, delivery, and payment providers into a single service. It lets travellers between Korea and Japan get treatment and receive medication during their stay.
Why it matters: Overseas care usually splits consultation, booking, prescription, payment, and delivery across different providers, causing customers to drop off. Visitors with fixed stays often abandon treatment after a single delay — a gap Mednext aims to close by bundling the process.
Where it stands: Mednext runs an online platform in Japan covering both insured and non-insured care, currently serving Koreans in Japan with non-insured treatment. Because it handles long-term medications, customers tend to return. It recently brought a Japanese subsidiary in-house to anchor the two-country operation.
What's the endgame? The company plans to add treatment categories and health products, upgrade its digital healthcare tools, and package its operations and technology into solutions for hospitals and corporate clients.
Why now? The fund backing the deal was formed this year to invest in startups linking Jeju and Japan, with the Jeju center serving as general partner. The center cited Mednext's grasp of both countries' medical systems and its local partner network as reasons for investing.
What they're saying: "Mednext is a company with experience in connecting the complex overseas treatment process end to end," said Lee Byung-sun, head of the Jeju center. He added that it would "continue to support" the company's growth into a Korea-Japan medical platform.
The signal: The vehicle fits the Jeju center's broader push to channel investment into local startups, part of a regional effort that includes a separate deep-tech and global venture fund. With the amount undisclosed and Mednext only months old, the round's weight as a cross-border bet remains hard to gauge.
Read more: wowtale.net
Image credit: Generated with Gemini
